This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Novartis Ag, Unversität Zürich. Active years: 2010-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2010-2013
Title: The Innovative Journey of Inventor Alessandra Vitaliti
Introduction
Alessandra Vitaliti, based in Bedigliora, Switzerland, is a remarkable inventor known for her contributions in the field of biotechnology. With two patents to her name, Alessandra's work primarily revolves around therapies aimed at nerve repair, showcasing her dedication to advancing medical science and technology.
Latest Patents
Alessandra's latest patents include the invention of Antibody (11C7) anti Nogo-A and its pharmaceutical use. This groundbreaking invention pertains to molecules such as monoclonal antibodies or their Fab fragments capable of binding to the human NogoA polypeptide and its variants. The binding is characterized by a dissociation constant of less than 1000 nM. The invention encompasses polynucleotides that encode such binding molecules, expression vectors housing these polynucleotides, and comprehensive methods for utilizing these molecules in the treatment of diseases linked to nerve repair. Additionally, this pharmaceutical composition demonstrates potential in addressing various disorders associated with nerve regeneration.
Career Highlights
Throughout her outstanding career, Alessandra has collaborated with prestigious institutions and companies, notably Novartis AG and the University of Zurich. Her work has had a profound impact on the field of neuroscience and regenerative medicine.
Collaborations
Alessandra has worked alongside esteemed colleagues, including Carmen Barske and Anis Khusro Mir. Their collective expertise and innovative spirit have further contributed to advancements in biopharmaceutical research, especially concerning therapies for nerve repair.
Conclusion
Alessandra Vitaliti stands as a testament to the spirit of innovation in the scientific community. Her patents, particularly in the realm of antibodies targeting Nogo-A, represent significant strides toward improving treatments for nerve-related conditions. With a career marked by collaborations at leading research institutions, she continues to inspire future inventors and researchers in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile